Logo image of LUXE

LUXEXPERIENCE BV (LUXE) Stock Fundamental Analysis

NYSE:LUXE - US55406W1036 - ADR

9.34 USD
+0.11 (+1.19%)
Last: 9/11/2025, 8:04:00 PM
Fundamental Rating

4

Taking everything into account, LUXE scores 4 out of 10 in our fundamental rating. LUXE was compared to 123 industry peers in the Specialty Retail industry. LUXE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. LUXE shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year LUXE was profitable.
In the past year LUXE had a positive cash flow from operations.
LUXE had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: LUXE reported negative operating cash flow in multiple years.
LUXE Yearly Net Income VS EBIT VS OCF VS FCFLUXE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M -60M

1.2 Ratios

With a Return On Assets value of -5.51%, LUXE is not doing good in the industry: 68.29% of the companies in the same industry are doing better.
LUXE has a Return On Equity (-9.22%) which is in line with its industry peers.
LUXE has a Return On Invested Capital of 2.14%. This is comparable to the rest of the industry: LUXE outperforms 46.34% of its industry peers.
Industry RankSector Rank
ROA -5.51%
ROE -9.22%
ROIC 2.14%
ROA(3y)-2.35%
ROA(5y)-2.32%
ROE(3y)-3.64%
ROE(5y)-1.89%
ROIC(3y)N/A
ROIC(5y)N/A
LUXE Yearly ROA, ROE, ROICLUXE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 5 -5

1.3 Margins

With a Operating Margin value of 1.47%, LUXE perfoms like the industry average, outperforming 47.15% of the companies in the same industry.
LUXE has a Gross Margin of 47.67%. This is in the better half of the industry: LUXE outperforms 74.80% of its industry peers.
In the last couple of years the Gross Margin of LUXE has remained more or less at the same level.
Industry RankSector Rank
OM 1.47%
PM (TTM) N/A
GM 47.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-0.15%
LUXE Yearly Profit, Operating, Gross MarginsLUXE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

More info and screens

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LUXE is destroying value.
Compared to 1 year ago, LUXE has more shares outstanding
LUXE has less shares outstanding than it did 5 years ago.
LUXE has a better debt/assets ratio than last year.
LUXE Yearly Shares OutstandingLUXE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
LUXE Yearly Total Debt VS Total AssetsLUXE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

LUXE has an Altman-Z score of 4.86. This indicates that LUXE is financially healthy and has little risk of bankruptcy at the moment.
LUXE has a Altman-Z score of 4.86. This is amongst the best in the industry. LUXE outperforms 85.37% of its industry peers.
LUXE has a debt to FCF ratio of 3.92. This is a good value and a sign of high solvency as LUXE would need 3.92 years to pay back of all of its debts.
LUXE has a better Debt to FCF ratio (3.92) than 68.29% of its industry peers.
A Debt/Equity ratio of 0.15 indicates that LUXE is not too dependend on debt financing.
LUXE has a better Debt to Equity ratio (0.15) than 65.04% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 3.92
Altman-Z 4.86
ROIC/WACC0.29
WACC7.29%
LUXE Yearly LT Debt VS Equity VS FCFLUXE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

LUXE has a Current Ratio of 1.85. This is a normal value and indicates that LUXE is financially healthy and should not expect problems in meeting its short term obligations.
LUXE has a Current ratio of 1.85. This is amongst the best in the industry. LUXE outperforms 80.49% of its industry peers.
LUXE has a Quick Ratio of 1.85. This is a bad value and indicates that LUXE is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of LUXE (0.30) is worse than 74.80% of its industry peers.
Industry RankSector Rank
Current Ratio 1.85
Quick Ratio 0.3
LUXE Yearly Current Assets VS Current LiabilitesLUXE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

7

3. Growth

3.1 Past

LUXE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 625.00%, which is quite impressive.
Looking at the last year, LUXE shows a quite strong growth in Revenue. The Revenue has grown by 8.13% in the last year.
Measured over the past years, LUXE shows a quite strong growth in Revenue. The Revenue has been growing by 17.27% on average per year.
EPS 1Y (TTM)625%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)8.13%
Revenue growth 3Y11.16%
Revenue growth 5Y17.27%
Sales Q2Q%3.68%

3.2 Future

Based on estimates for the next years, LUXE will show a very strong growth in Earnings Per Share. The EPS will grow by 34.30% on average per year.
Based on estimates for the next years, LUXE will show a very strong growth in Revenue. The Revenue will grow by 45.81% on average per year.
EPS Next Y40.25%
EPS Next 2Y-120.17%
EPS Next 3Y34.3%
EPS Next 5YN/A
Revenue Next Year44.22%
Revenue Next 2Y75.97%
Revenue Next 3Y45.81%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
LUXE Yearly Revenue VS EstimatesLUXE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
LUXE Yearly EPS VS EstimatesLUXE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 27.47, LUXE can be considered very expensive at the moment.
LUXE's Price/Earnings ratio is a bit cheaper when compared to the industry. LUXE is cheaper than 64.23% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.43, LUXE is valued at the same level.
LUXE is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 27.47
Fwd PE N/A
LUXE Price Earnings VS Forward Price EarningsLUXE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, LUXE is valued a bit more expensive than 62.60% of the companies in the same industry.
LUXE's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 61.02
EV/EBITDA 34.95
LUXE Per share dataLUXE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

LUXE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
LUXE's earnings are expected to grow with 34.30% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.68
PEG (5Y)N/A
EPS Next 2Y-120.17%
EPS Next 3Y34.3%

More info and screens

0

5. Dividend

5.1 Amount

LUXE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LUXEXPERIENCE BV

NYSE:LUXE (9/11/2025, 8:04:00 PM)

9.34

+0.11 (+1.19%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)09-10 2025-09-10/amc
Earnings (Next)11-17 2025-11-17
Inst Owners14.69%
Inst Owner Change-5.09%
Ins Owners0.9%
Ins Owner ChangeN/A
Market Cap1.27B
Analysts76.36
Price Target11.6 (24.2%)
Short Float %3.7%
Short Ratio4.67
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)539%
Min EPS beat(2)96.08%
Max EPS beat(2)981.91%
EPS beat(4)3
Avg EPS beat(4)308.49%
Min EPS beat(4)-50.98%
Max EPS beat(4)981.91%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.62%
Min Revenue beat(2)-3.63%
Max Revenue beat(2)0.39%
Revenue beat(4)1
Avg Revenue beat(4)-2.74%
Min Revenue beat(4)-4.69%
Max Revenue beat(4)0.39%
Revenue beat(8)3
Avg Revenue beat(8)-1.37%
Revenue beat(12)4
Avg Revenue beat(12)-1.92%
Revenue beat(16)6
Avg Revenue beat(16)-1.54%
PT rev (1m)0%
PT rev (3m)-3.87%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-309.99%
EPS NY rev (1m)0%
EPS NY rev (3m)-62.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)122.83%
Revenue NY rev (1m)0%
Revenue NY rev (3m)9.6%
Valuation
Industry RankSector Rank
PE 27.47
Fwd PE N/A
P/S 1.23
P/FCF 61.02
P/OCF 48.4
P/B 2.62
P/tB 4.18
EV/EBITDA 34.95
EPS(TTM)0.34
EY3.64%
EPS(NY)-0.27
Fwd EYN/A
FCF(TTM)0.15
FCFY1.64%
OCF(TTM)0.19
OCFY2.07%
SpS7.62
BVpS3.56
TBVpS2.23
PEG (NY)0.68
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.51%
ROE -9.22%
ROCE 2.86%
ROIC 2.14%
ROICexc 2.21%
ROICexgc 3.31%
OM 1.47%
PM (TTM) N/A
GM 47.67%
FCFM 2.01%
ROA(3y)-2.35%
ROA(5y)-2.32%
ROE(3y)-3.64%
ROE(5y)-1.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-0.15%
F-Score5
Asset Turnover1.28
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 3.92
Debt/EBITDA 1.94
Cap/Depr 24.48%
Cap/Sales 0.52%
Interest Coverage 2.5
Cash Conversion 70.23%
Profit Quality N/A
Current Ratio 1.85
Quick Ratio 0.3
Altman-Z 4.86
F-Score5
WACC7.29%
ROIC/WACC0.29
Cap/Depr(3y)134.72%
Cap/Depr(5y)94.09%
Cap/Sales(3y)2.03%
Cap/Sales(5y)1.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)625%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
EPS Next Y40.25%
EPS Next 2Y-120.17%
EPS Next 3Y34.3%
EPS Next 5YN/A
Revenue 1Y (TTM)8.13%
Revenue growth 3Y11.16%
Revenue growth 5Y17.27%
Sales Q2Q%3.68%
Revenue Next Year44.22%
Revenue Next 2Y75.97%
Revenue Next 3Y45.81%
Revenue Next 5YN/A
EBIT growth 1Y280.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year40.96%
EBIT Next 3Y84.01%
EBIT Next 5YN/A
FCF growth 1Y122.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y144.07%
OCF growth 3YN/A
OCF growth 5Y33.41%